CORC

浏览/检索结果: 共3条,第1-3条 帮助

限定条件    
已选(0)清除 条数/页:   排序方式:
Randomized phase III trial of utidelone, a genetically engineered epothilone analog, in combination with capecitabine versus capecitabine alone for metastatic breast cancer patients with previous taxane and anthracycline treatment. 会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2016-05-20
作者:  Xu, Binghe;  Sun, Tao;  Zhang, Qingyuan;  Yuan, Zhongyu;  Zhang, Pin
收藏  |  浏览/下载:4/0  |  提交时间:2020/01/04
Outcomes of re-treatment with first-line trastuzumab plus taxane in patients (pts) with metastatic breast cancer (mBC) who relapsed after (neo)adjuvant trastuzumab: A prospective multicenter study. 会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2016-05-20
作者:  Xu, Binghe;  Hu, Xi-Chun;  Zheng, Hong;  Wang, Xiaojia;  Zhang, Qingyuan
收藏  |  浏览/下载:6/0  |  提交时间:2020/01/04
The feasibility of the ACOSOG Z0011 criteria for omitting axillary lymph node dissection after positive sentinel lymph node biopsy in Chinese breast cancer patients: A multicenter study. 会议论文
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, MAY 29-JUN 02, 2015
作者:  Liu, Miao;  Cui, Shude;  Duan, Xuening;  Fan, Zhimin;  Yu, Zhigang
收藏  |  浏览/下载:4/0  |  提交时间:2019/12/31


©版权所有 ©2017 CSpace - Powered by CSpace